MIACALCIC spray nasal 200 U/dose fl

7680474730028 CH-47473 H05BA01 07.05.2.

Reimbursement limitations:

MIACALCICNAS

Les traitements nécessitent l’autorisation de l’assurance maladie, après consultation préalable du médecin-conseil.
Prévention de l’ostéoporose: …

MIACALCIC spray nasal 200 U/dose fl
MIACALCIC spray nasal 200 U/dose fl
1 / 2
google

Details

Product number
4747303
CPT
-
Packaging group
1
Unit
Flasche(n)
Composition
calcitoninum salmonis 200 U.I., natrii chloridum, acidum hydrochloridum 25 per centum, benzalkonii chloridum 0.009 mg, aqua purificata, ad solutionem pro dosi.

Articles (1)

Miacalcic 200, Nasenspray
Nasenspray
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/04/2023
Patient information leaflet
Français
18/04/2023
Patient information leaflet
Italien
18/04/2023
Professional SmPC
Allemand
18/04/2023
Professional SmPC
Français
18/04/2023
Professional SmPC
Italien
18/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.009 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 59.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
47473
Drug name
Miacalcic, Nasenspray
Galenic form
NASSL
ATC Code
H05BA01
Authorization status
Z
Dispensation category
B
First authorization
18/03/1986
Authorization expiration date
31/12/9999
IT number
07.05.2.
Domain
Human medicine
Field of application
Osteoporoseprävention, Morbus Paget, Neurodystrophische Störungen

Packaging details

Description (FR)
MIACALCIC spray nasal 200 U/dose fl
Description (DE)
MIACALCIC Nasenspray 200 E/Dosis Fl
Market launch
16/02/1998
Narcotic (BTM)
No

Other packaging sizes